Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature
Doerfler, L.; Hanke, C..William.
Journal of Drugs in Dermatology Jdd 18(7): 693-696
2019
ISSN/ISBN: 1545-9616 PMID: 31334929 Document Number: 17921
Keratoacathoma (KA) is a unique clinical pathological entity that is difficult to categorize. Differentiating a KA from a squamous cell carcinoma (SCC) is important for treatment implications but is often challenging. We report a patient with a solitary KA of the skin of the right ala successfully treated with intralesional (IL) injections of methotrexate (MTX). We also provide a review of the literature on IL-MTX as a treatment modality for KA.
Document emailed within 1 workday